Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kodak Mammography CAD System On Track For Early 2004 Launch

This article was originally published in The Gray Sheet

Executive Summary

FDA approval of Kodak's first computer-aided detection system would endorse premarket data suggesting the CAD can detect 39.4% of missed cancerous breast tumors 14.8 months earlier than mammography alone

You may also be interested in...



Kodak “PACS” Digital Suitcase With $42.5 Mil. Algotec Acquisition

Eastman Kodak aims to increase its revenue drawn from digital technologies from 30% to 60% of sales over the next three years to help achieve the company's goal of becoming a $16 bil. business by 2006

Kodak “PACS” Digital Suitcase With $42.5 Mil. Algotec Acquisition

Eastman Kodak aims to increase its revenue drawn from digital technologies from 30% to 60% of sales over the next three years to help achieve the company's goal of becoming a $16 bil. business by 2006

Hologic Aims To Double Selenia FFDM System Unit Sales In 2004 To Over 100

Hologic expects its recent distribution deal for Aloka ultrasound equipment to be followed in December by similar contracts for additional imaging systems to round out its core women's health offerings

Latest Headlines
See All
UsernamePublicRestriction

Register

MT019330

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel